Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

RiboX wins FDA clearance for first circular RNA CAR therapy

RiboX Therapeutics received FDA IND clearance for RXIM002 the first circular RNA based in vivo CAR therapy for autoimmune cytopenias supporting the initiation of its Phase 1 clinical trial

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Health & Medicine

More from Monday 10 August →